Model of cryptogenic infantile spasms after prenatal corticosteroid priming

Libor Velísek1, Tamar Chachua, Mi-Sun Yum

  • 1The Saul R Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. libor.velisek@einstein.yu.edu

Epilepsia
|July 13, 2010
PubMed

Insights

A new rat model mimics infantile spasms (IS), a severe childhood epilepsy. This model, induced by NMDA and betamethasone, shows promise for developing safer, novel IS therapies.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pediatric Neurology

Background:

  • Infantile spasms (IS) is a severe epilepsy syndrome in infants (3-12 months old).
  • Current hormonal therapies like ACTH and corticosteroids have significant side effects.
  • A validated animal model is crucial for researching novel IS treatments.

Purpose of the Study:

  • To develop and validate an animal model for infantile spasms.
  • To investigate the neurobiological underpinnings of IS using this model.

Main Methods:

  • Infant rats were prenatally exposed to betamethasone.
  • Spastic seizures were triggered using N-methyl-d-aspartate (NMDA).
  • Electroencephalography (EEG), autoradiographic metabolic mapping, and c-fos expression were used to analyze seizure activity and neuronal involvement.

Main Results:

  • The model exhibited spasms similar to human IS, including motor flexion and EEG electrodecrement.
  • The spasms responded to ACTH, a known IS treatment.
  • Neuronal excitation primarily involved hypothalamic structures like the arcuate nucleus, with minimal hippocampal involvement.

Conclusions:

  • This NMDA-induced seizure model in betamethasone-exposed infant rats effectively mimics key features of human infantile spasms.
  • The model's reliance on hypothalamic structures offers new insights into IS pathophysiology.
  • This validated model is suitable for preclinical research into novel infantile spasms therapies.

Related Concept Videos

Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...